Depression Clinical Trial
— PEARLOfficial title:
PEARL Intervention to Reduce Depression Among Adults With Epilepsy
Verified date | June 2008 |
Source | University of Washington |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
The purpose of this study is to test the effectiveness of a home-based depression treatment intervention called "Program to Encourage Active, Rewarding Lives (PEARL)". We hypothesize that over a 12-month period, compared to usual care, those receiving the PEARL intervention will show more improvement with their depression, have higher quality of life and function, and use fewer medical services.
Status | Active, not recruiting |
Enrollment | 80 |
Est. completion date | March 2009 |
Est. primary completion date | March 2009 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Home address within 30 miles of Seattle - Diagnosis of epilepsy (ICD-9 code 345.XX) - Appointment in the UW REC or Neurology clinic in the past 2 years and currently enrolled in this clinic. - Current age older than 18 years - Diagnosis of major depression, minor depression or dysthymia - Ability to speak/read English Exclusion Criteria: - Alcohol and/or substance abuse/dependence based on a score greater than 1 on 4-item validated CAGE-AID - Cognitive impairment based on a score less than 3 on a 6-item validated cognitive screen - Diagnosis of bipolar disorder, schizophrenia/schizoaffective disorder or other psychotic disorder - Women who are pregnant or nursing - Terminal medical illness - Those currently seeing or planning to see a psychiatrist - Those with suicidal ideation nearly every day |
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Regional Epilepsy Center, Harborview Medical Center | Seattle | Washington |
Lead Sponsor | Collaborator |
---|---|
University of Washington | Centers for Disease Control and Prevention |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Mean SCL-20 depression scores | 6 & 12 months post-baseline | No | |
Primary | Depression treatment response, defined as greater than 50% decrease in SCL-20 score from baseline | 6 & 12 months post-baseline | No | |
Primary | Complete depression remission defined as SCL-20 score less than 0.5. | 6 & 12 months post-baseline | No | |
Secondary | Quality of Life | 6 & 12 months post-baseline | No | |
Secondary | Pharmaceutical and health care utilization and costs | 6 & 12 months post-baseline | No | |
Secondary | Seizure frequency and severity | 6 & 12 months post-baseline | No | |
Secondary | Satisfaction with epilepsy health care | 6 & 12 months post-baseline | No | |
Secondary | Epilepsy Self-Efficacy | 6 & 12 months post-baseline | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05777044 -
The Effect of Hatha Yoga on Mental Health
|
N/A | |
Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
Recruiting |
NCT04977232 -
Adjunctive Game Intervention for Anhedonia in MDD Patients
|
N/A | |
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Completed |
NCT04476446 -
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
|
Phase 3 | |
Recruiting |
NCT02783430 -
Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
|
Phase 2/Phase 3 | |
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Completed |
NCT04598165 -
Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support
|
N/A | |
Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
Recruiting |
NCT05956912 -
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
|
||
Completed |
NCT05588622 -
Meru Health Program for Cancer Patients With Depression and Anxiety
|
N/A | |
Recruiting |
NCT05234476 -
Behavioral Activation Plus Savoring for University Students
|
N/A | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A |